Stockscreener 앱 받기
2.17
5.85%
0.12
Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스
Live market analysis of ProQR Therapeutics N.V.Breakout Screener With Alert Based Timing - Newser
Using Ichimoku Cloud for ProQR Therapeutics N.V. technicalsFree Price Action Based Buy Opportunity List - Newser
ProQR Therapeutics (NASDAQ:PRQR) Shares Pass Above 50-Day Moving AverageTime to Sell? - MarketBeat
Ranking ProQR Therapeutics N.V. among high performing stocks via toolsTechnical Safety Zone Pattern Recognition - Newser
ProQR Therapeutics (PRQR) to Release Earnings on Thursday - MarketBeat
Real time breakdown of ProQR Therapeutics N.V. stock performanceSecure Entry Point Finder with Analysis - Newser
How high can ProQR Therapeutics N.V. stock goAI Trading Forecast Based on Big Data - Newser
Buy Signal for ProQR Therapeutics N.V. Stock Key Technical Indicators to WatchLow Risk Stock Trade Opportunity Analysis - Newser
Chardan Capital Reaffirms Buy Rating for ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
Analyzing ProQR Therapeutics N.V. with risk reward ratio chartsFree Swing Trading Entry Point Signals - Newser
Is ProQR Therapeutics N.V. stock a growth or value playChart Pattern Recognition for Profit Timing - Newser
How to forecast ProQR Therapeutics N.V. trends using time seriesReal-Time Equity Price Action Analysis - Newser
Can ProQR Therapeutics N.V. recover in the next quarterHigh Accuracy Trade Setup Identification - Newser
ProQR: Q2 Earnings Snapshot - Manistee News Advocate
How institutional ownership impacts ProQR Therapeutics N.V. stockFree Breakout Momentum Picks With Protection - Newser
ProQR Therapeutics shares rise 3.17% intraday after reporting a Q2 loss of $13.8 million, missing Wall Street expectations. - AInvest
ProQR Therapeutics Reports Q2 Earnings: $13.8mln Loss, $4.3mln Revenue - AInvest
Real time alert setup for ProQR Therapeutics N.V. performanceDeep Learning Stock Forecast for Investors - Newser
Published on: 2025-08-08 07:28:56 - Newser
Using economic indicators to assess ProQR Therapeutics N.V. potentialFree Growth Based Investment Plan Guidance - Newser
Statistical indicators supporting ProQR Therapeutics N.V.’s strengthFree Community Shared Smart Money Signals - Newser
ProQR Therapeutics NV reports results for the quarter ended June 30Earnings Summary - TradingView
ProQR Therapeutics NV earnings missed by €0.04, revenue fell short of estimates - Investing.com
ProQR Reports Q2 2025 Financial Results Amid Rising R&D Costs - TipRanks
ProQR Announces Second Quarter 2025 Operating and Financial Resu - GuruFocus
ProQR Therapeutics Updates on AX-0810 Clinical Trial Submission and Financial Results for Q2 2025 - Quiver Quantitative
ProQR Announces Second Quarter 2025 Operating and Financial Results - GlobeNewswire
ProQR's RNA Editing Breakthrough: First Clinical Trial Launch, €120M War Chest, and Expanding Lilly Partnership - Stock Titan
Is ProQR Therapeutics N.V. stock ready for a breakoutProven Trading System with Consistent Gains - Newser
Why ProQR Therapeutics N.V. stock attracts strong analyst attentionStock Holding Strategy Long-Term Summary Sheet - Newser
ProQR Therapeutics (PRQR) Expected to Announce Earnings on Thursday - Defense World
ProQR Therapeutics N.V. stock outlook for YEARFree Consistent Gain Investment Strategies - Newser
What to do if you’re stuck in ProQR Therapeutics N.V.Short-Term Profit Alert With Entry Forecast - Newser
Will breakout in ProQR Therapeutics N.V. lead to full recoveryConsistent Return Setup with Exit Strategy - Newser
ProQR Therapeutics N.V. Company Revenue and Profit Trends: A Deep DiveBuy and Hold Return Summary with Charts - Newser
Chart Analysts Warn of Resistance Near ProQR Therapeutics N.V. PriceBreakout Confirmation With Entry Tracker Enabled - metal.it
What makes ProQR Therapeutics N.V. stock price move sharplyROI Focused Setup Screener With Exit Markers - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):